Yüklüyor......
Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome
OBJECTIVE: The European Increlex(®) Growth Forum Database Registry monitors the effectiveness and safety of recombinant human insulin-like growth factor-1 (rhIGF1; mecasermin, Increlex(®)) therapy in patients with severe primary IGF1 deficiency (SPIGFD). We present data from patients with and withou...
Kaydedildi:
| Yayımlandı: | Eur J Endocrinol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Bioscientifica Ltd
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7849377/ https://ncbi.nlm.nih.gov/pubmed/33434161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EJE-20-0325 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|